Type 1 diabetes

Hypoglycaemia symptom frequency, severity, burden, and utility among adults with type 1 diabetes and impaired awareness of hypoglycaemia: Baseline and 24‐week findings from the HypoCOMPaSS study

Diabet MedPublished Secondary analysis of the HypoCOMPaSS study

Authors' conclusion

Adults with T1D and IAH experience a range of hypoglycaemia symptoms. Perceptions of symptom burden or utility are malleable. Although larger scale studies are needed to confirm, these findings suggest that changing the salience of the symptomatic response may be more important in recovering protection from hypoglycaemia through regained awareness than intensifying symptom frequency or severity.

Study context

Population
Adults with T1D (duration 29 ± 12 years; 64% women) and impaired awareness of hypoglycaemia (IAH)
Participants
96 adults
Comparison
Baseline vs week 24 following the HypoCOMPaSS awareness restoration intervention
Primary endpoint
Frequency, severity, burden and utility of hypoglycaemia symptoms (Hypoglycaemia Burden Questionnaire, 20 pre-specified symptoms)
Follow-up
Baseline and week 24

Primary result

As reported in the abstract

Hypoglycaemia symptoms at baseline

Experienced at least one symptom

93

97%

Number of symptoms, mean ± SD

10.6 ± 4.6

Proportion recognising each specific symptom

15% to 83%

Further findings

Symptom severity, burden and utility · 24 weeks

Symptom severity and burden appear reduced, and utility increased

Original publication

Hypoglycaemia symptom frequency, severity, burden, and utility among adults with type 1 diabetes and impaired awareness of hypoglycaemia: Baseline and 24‐week findings from the HypoCOMPaSS study. Diabet Med. Published 9 October 2023. doi:10.1111/dme.15231

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.